
Results
21
Companies which are more than 50% undervalued based on analyst price target.
21 companies
Samsung Epis Holdings
Market Cap: ₩9.4t
A biotechnology company, manage the portfolio of biopharmaceutical products.
A0126Z0
₩380,000.00
7D
4.5%
1Y
n/a
ABL Bio
Market Cap: ₩4.2t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩74,600.00
7D
-6.4%
1Y
-21.3%
LigaChem Biosciences
Market Cap: ₩3.6t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩98,300.00
7D
-5.8%
1Y
-34.2%
Voronoi
Market Cap: ₩3.0t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩165,800.00
7D
-6.0%
1Y
33.3%
ST PharmLtd
Market Cap: ₩2.3t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩110,000.00
7D
10.8%
1Y
16.3%
Daewoong Pharmaceutical
Market Cap: ₩1.5t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩128,000.00
7D
8.2%
1Y
-7.2%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩35,900.00
7D
-5.8%
1Y
-3.0%
L&C BIOLTD
Market Cap: ₩1.4t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩50,700.00
7D
-2.1%
1Y
70.4%
DongKook Pharmaceutical
Market Cap: ₩866.1b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩19,200.00
7D
6.7%
1Y
12.3%
Boryung
Market Cap: ₩763.7b
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
A003850
₩9,040.00
7D
0.6%
1Y
8.1%
Pharmicell
Market Cap: ₩653.4b
A biopharmaceutical company, develops and sells autologous drugs in South Korea and internationally.
A005690
₩10,890.00
7D
-4.3%
1Y
1.8%
Dong-A Socio Holdings
Market Cap: ₩620.5b
Engages in the pharmaceutical business in South Korea.
A000640
₩93,600.00
7D
6.1%
1Y
-13.1%
AprilBioLtd
Market Cap: ₩527.9b
Develops long-acting type biobetter and antibody biologics.
A397030
₩19,190.00
7D
-27.0%
1Y
-14.1%
Dong-A ST
Market Cap: ₩370.1b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩38,400.00
7D
4.5%
1Y
-10.2%
Humedix
Market Cap: ₩265.7b
Engages in the manufacture and sale of various pharmaceutical products in South Korea.
A200670
₩25,750.00
7D
0.8%
1Y
-52.8%
BINEX
Market Cap: ₩231.9b
Operates as a pharmaceutical company in South Korea.
A053030
₩7,280.00
7D
10.8%
1Y
-55.0%
Whan In PharmLtd
Market Cap: ₩188.0b
Manufactures and sells various pharmaceutical products in South Korea.
A016580
₩10,170.00
7D
2.4%
1Y
-5.6%
Daewon Pharmaceutical
Market Cap: ₩168.9b
A pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea.
A003220
₩7,880.00
7D
1.5%
1Y
-40.0%
Daihan PharmaceuticalLtd
Market Cap: ₩156.1b
Engages in the manufacture and sale of therapeutic drugs in South Korea.
A023910
₩26,550.00
7D
1.5%
1Y
-11.4%
Macrogen
Market Cap: ₩138.7b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩12,790.00
7D
5.9%
1Y
-18.2%
Samil PharmaceuticalLtd
Market Cap: ₩134.8b
Engages in the manufacture and sale of pharmaceuticals in South Korea.
A000520
₩6,310.00
7D
1.4%
1Y
-35.8%